Opportunities and challenges in psychopharmacology .
Opportunities and challenges in psychopharmacology . Dialogues Clin Neurosci. 2019;21(2):119-130 Authors: Schulz P Abstract This review addresses novel approaches for influencing the transcriptome, the epigenome, the microbiome, the proteome, and the energy metabolome. These innovations help develop psychotropic medications which will directly reach the molecular targets, leading to beneficial effects, and which will be individually adapted to provide more efficacy and less toxicity. The series of advances described here show that these once utopian goals for psychiatric treatment are now real themes of research, indicating that the future path for psychopharmacology might not be as narrow and grim as considered during the last few decades. . PMID: 31636486 [PubMed - in process]
Bayer submits application to European Medicines Agency for pre-filled syringe to administer eye medication Eylea®mehr ...
Conclusion: New lesions at the reference MRI in terms of number and topography increase the risk of radiological disease activity during the follow up. PMID: 31959078 [PubMed - as supplied by publisher]
MiR-29a-3p/NID1 axis regulates pulmonary fibrosis induced by TGF-β1. Panminerva Med. 2020 Jan 20;: Authors: Lin L, Qu W, Li Y, Zhu H, Jiang W PMID: 31961112 [PubMed - as supplied by publisher]
Authors: Zhang J, Guo Y, Jia T, Guo H, Meng F, Xue S PMID: 31961111 [PubMed - as supplied by publisher]
Authors: Gao J, Zhao G, Wang P, Li S, Wang X, Zhao H PMID: 31961110 [PubMed - as supplied by publisher]
Authors: Wang X, Wen Y, Xue L, Lu R, Tang H, Gao N, Zhang J, Xue Q PMID: 31961109 [PubMed - as supplied by publisher]
Authors: Wang P, Xue L, Wang L, Tang H, Lv C, Xue Q PMID: 31961108 [PubMed - as supplied by publisher]
Authors: Luan J, Liu Y, Liu H, Wang Z PMID: 31961114 [PubMed - as supplied by publisher]